Cover Image

Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry

Saved in:

Bibliographic Details
Main Authors:	Cihan Altın (Author), Caner Topaloğlu (Author), Nurullah Çetin (Author), Onur Dalgıç (Author), Veysel Yavuz (Author), Emin Alioğlu (Author), Nazile Bilgin (Author), Cenk Ekmekçi (Author), Nihat Pekel (Author), Mehmet Emre Özpelit (Author), Eşref Tunçer (Author), Ebru İpek Türkoğlu (Author), Kamil Tülüce (Author), Umut Kocabaş (Author), Kıvanç Yüksel (Author), Uğur Önsel Türk (Author)
Format:	Book
Published:	KARE Publishing, 2021-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design and rationale of dabigatran's stroke prevention in real life in Turkey (D-SPIRIT)
by: Uğur Önsel Türk, et al.
Published: (2016)

Spontaneous spinal epidural hematoma developing after percutaneous coronary intervention: early diagnosis, early intervention, and good outcome
by: Ferhat Özyurtlu, et al.
Published: (2016)

İnflamatuar papiller hiperplazi olgusunun kriyocerrahi yöntemi ile tedavisi: olgu raporu
by: Bedriye Çelebioğlu, et al.
Published: (2011)

İnflamatuar papiller hiperplazi olgusunun kriyocerrahi yöntemi ile tedavisi: olgu raporu
by: Bedriye Gizem Çelebioğlu, et al.
Published: (2011)

Stable coronary artery disease management: What has changed in the 2013 European Society of Cardiology guideline?
by: M. Emre Özpelit, et al.
Published: (2014)

Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report
by: Uğur Önsel Türk, et al.
Published: (2019)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
by: Jong-Min Kim, et al.
Published: (2022)

The Discovery of Dabigatran Etexilate
by: Joanne evan Ryn, et al.
Published: (2013)

Pharmacokinetics and Pharmacogenetics of Dabigatran
by: A. V. Savinova, et al.
Published: (2021)

Rationale and design of the Myocardial Infarction with Non-obstructive Coronary Arteries in Turkish Population (MINOCA-TR) study
by: Uğur Önsel Türk, et al.
Published: (2019)

The new way of Dabigatran reversal - Idarucizumab
by: Erwin Ciechański, et al.
Published: (2019)

DABIGATRAN AND DENTAL EXTRACTIONS - Case Report
by: Atanaska S. Dinkova, et al.
Published: (2017)

The new way of Dabigatran reversal - Idarucizumab
by: Erwin Ciechański, et al.
Published: (2019)

HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. V. Moiseev
Published: (2015)

HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. V. Moiseev
Published: (2015)

SAFETY ISSUES IN THE TREATMENT OF PATIENTS TAKING DABIGATRAN
by: E. S. Kropacheva
Published: (2016)

DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS
by: N. M. Vorobieva, et al.
Published: (2015)

The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation
by: Guy A. Richards, et al.
Published: (2018)

Use of idarucizumab for emergency surgery in patients taking dabigatran
by: O. M. Nesterova, et al.
Published: (2022)

DABIGATRAN AND IDARUZIZUMAB. NEW OPPORTUNITIES FOR IMPROVING PATIENT SAFETY
by: N. A. Novikova, et al.
Published: (2019)

Severe thrombosis of bioprosthesis mitral valve after dabigatran
by: Çağdaş Akgüllü, et al.
Published: (2013)

Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration
by: Yuuki Akagi, et al.
Published: (2019)

Dabigatran etexilate - A novel oral anticoagulant for bleeding complications
by: Himabindu Reddy, et al.
Published: (2015)

Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran
by: Sié P
Published: (2016)

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis
by: Ya Zhou, et al.
Published: (2021)

Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
by: Josef Finsterer, et al.
Published: (2012)

Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects
by: Hyewon Chung, et al.
Published: (2023)

Body Osteotomıes (Reports Of 13 Cases)
by: Orhan Güven, et al.
Published: (1995)

Dabigatran in the Treatment of Warfarin-Induced Skin Necrosis: A New Hope
by: Christos Bakoyiannis, et al.
Published: (2016)

PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Kosmacheva, et al.
Published: (2015)

PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Kosmacheva, et al.
Published: (2015)

Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice
by: Kun Shi, et al.
Published: (2017)

The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations
by: E. S. Kropacheva, et al.
Published: (2023)

IDARUCIZUMAB, A SPECIFIC REVERSAL AGENT FOR DABIGATRAN: THE PRESENT-DAY KNOWLEDGE
by: Olga O. Shakhmatova
Published: (2018)

Serum Caspase-1 levels in women with polycystic ovary syndrome
by: Umit Cabus, et al.
Published: (2020)

Stafne kemik kavitesi: 3 olgu sunumu
by: Gizem Celebioglu, et al.
Published: (2012)

Monitoring the use of dabigatran etexilate for stroke prevention: compliance with renal function guidelines
by: Alesha J. Smith, et al.
Published: (2020)

Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
by: Proietti M, et al.
Published: (2018)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016)

Dabigatran must be used carefully: literature review and recommendations for management of adverse events
by: Lin S, et al.
Published: (2019)